Abstract P2012: Combining the Anti-Fibrotic Actions of Serelaxin With the Anti-Oxidant, N-Acetylcysteine, Abrogates Cardiac Fibrosis in an Isoprenaline-Induced Murine Model of Cardiomyopathy

Oxidative stress is a significant contributor to cardiac fibrosis, particularly in the setting of hypertension. While current frontline medications (such as ACE inhibitors) and anti-oxidants (such ...